A Randomized Control Trial for Preventative Scar Management
Completed · Not applicable
Conditions studied: Hypertrophic Scarring
In brief
The study's objective is to compare the global scar outcomes in those treated with silicone only therapy (SOT) versus silicone pressure garment therapy (SPGT) for the prevention of hypertrophic scarring in children with skin grafts after traumatic skin injury.
Key facts
- Study ID
- NCT01602458
- Run by
- Seton Healthcare Family
- People needed
- 12
- Starts
- 2011-05-01
- Expected to finish
- 2013-11-01
- Last updated by the study team
- 2019-05-20
Who can join
Age: 1 and older, up to 18. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- patients who have undergone surgery within one month prior to enrollment
- patient must have a split-thickness or full thickness skin graft with extremity involvement secondary to a traumatic skin injury (burn, laceration, avulsion or de-gloving type injury) that has healed (based on clinician assessment of wound healing)
- patients with comorbid conditions
- patients must be referred to and attend scar management clinic at DCMC
You may not qualify if…
- patients with concave scars at the site of the skin graft
- patients with skin graft scars larger than 4x7 inches
- patients with presence of current skin infection or history of dermatological condition such as eczema
- patients with skin grafts only on parts of the body other than extremities
- patients with reported silicone allergies
Where it is running
- Dell Children's Medical Center of Central Texas — Austin, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.